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1. ABSTRACT 
 
p120 catenin (p120ctn), a component of the 
cadherin-catenin complex, was the first member to be 
identified in a most interesting subfamily of the Armadillo 
family. Several p120ctn isoforms are generated by 
alternative splicing. These isoforms fulfill pleiotropic 
functions according to their subcellular localization: 
modulating the turnover rate of membrane-bound 
cadherins, regulating the activation of small Rho GTPases 
in the cytoplasm, and modulating nuclear transcription. 
Over the last two decades, knowledge of p120ctn has 
grown remarkably, and this has been achieved in part by 
using different animal models. At least in frog and 
mammals, p120ctn is essential for normal development and 
homeostasis. Here we will discuss the effects of different 
p120ctn isoforms on cadherin turnover and on signaling in 
the cytoplasm and the nucleus. We will also elaborate on 
the structure and function of other members of the p120ctn 
subfamily: ARVCF, p0071 and delta-catenin. Finally, we 
will overview the respective roles of p120ctn family 
members in pathological processes, and particularly in 
cancer as p120ctn is frequently downregulated or 
mislocalized in various human tumors.  
 
 
 
 
2. OVERVIEW OF P120CTN RESEARCH 
 
 The founder of the p120ctn family was identified 
in 1989 as a most efficient substrate for the oncogenic Src 
tyrosine kinase (1). A 120-kDa protein (hence the name 
p120) was detected by phosphotyrosine-specific antibodies 
in cells expressing pp60527F, an oncogenic c-Src mutant, but 
it was not detected in cells expressing a non-membrane-
associated pp602A/527F double mutant. This protein was then 
found to associate with the cytoplasmic domains of 
cadherins, hence the descriptor 'catenin' and the protein 
name p120ctn. The mouse p120ctn cDNA was cloned in a 
labor-intensive manner in 1992 and the predicted protein 
was found to encode Armadillo repeats like those of beta-
catenin (2). The Armadillo repeat domain of p120ctn, like 
that of beta-catenin, was found to interact with E-cadherin, 
a component of the adherens junction (3). The mouse gene 
Ctnnd1 was localized on chromosome 2, whereas the 
human gene CTNND1 was localized on chromosome 11q11 
(4, 5). More recently, the relationship between p120ctn and 
E-cadherin was further elucidated by generating p120ctn-
uncoupled E-cadherin mutants, as well as by knockdown 
and knockout studies (Sections 5 and 8). Using a very 
reliable monoclonal antibody (pp120), which recognizes an 
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Figure 1. p120ctn performs different functions in different subcellular locations. Adherens junctions consist of transmembrane 
cadherins, which can bind via their cytoplasmic tails to beta-catenin and p120ctn. Beta-catenin binds to alpha-catenin, which can 
link to the actin cytoskeleton via an adaptor (e.g. Eplin) or as an unbound dimeric complex. p120ctn binds to the juxtamembrane 
domain of cadherins and prevents their endocytosis. Internalized cadherin molecules can be recycled or targeted for degradation. 
Cytoplasmic p120ctn can regulate RhoGTPase activity, whereas p120ctn shuttling between nucleus and cytoplasm can inhibit 
Kaiso-mediated transcriptional repression  
 
epitope in the C-terminal part of p120ctn, four main protein 
isoforms differing from each other by the length of their N-
termini and by alternative exon usage could be 
distinguished (3). Detailed analysis of human p120ctn 
transcripts revealed that an even larger diversity (48 
predictable isoforms) of the p120ctn protein can be 
generated by alternative splicing (Section 3) (6). Further 
investigation of p120ctn isoforms showed that they are 
differentially expressed under several conditions, pointing 
to specific roles in development and disease, and 
particularly in cancer (Section 9). Along with the 
identification of p120ctn isoforms came the identification 
of p120cn family members, such ARVCF (Armadillo 
repeat gene deleted in Velo-Cardio-Facial syndrome), 
p0071 and delta-catenin/NPRAP/neurojungin (neural 
plakophilin-related Armadillo protein), and the more 
distantly related plakophilins 1-3 (Section 4) (reviewed in 
7, 8). 
 
Besides binding to membrane-bound cadherins, 
p120ctn can also perform functions in the cytoplasm and in 
the nucleus by interacting with RhoGTPases and Kaiso, 
respectively (Figure 1). The first hint about the role of 
cytoplasmic p120ctn came from overexpression studies. 
Indeed, strong overexpression of p120ctn saturated the 
cadherin-binding sites, and the excess p120ctn translocated 
to the cytoplasm, where it induced extensions that were 
neurite-like (9). Additional research revealed that p120ctn 
elicits a 'dendritic-like branching' phenotype by modulating 
RhoGTPase activity (10-12), and this was confirmed by 
genetic and RNAi-mediated ablation of p120ctn. Because 
p120ctn interacts physically with the transcription factor 
Kaiso (13), a nuclear function for p120ctn was envisioned. 
Indeed, p120ctn can tether away Kaiso from the nucleus, 
preventing its transcriptional repression activity (Section 
7). During the last decade, all those research leads were 
further pursued to gain some mechanistic insight into 
p120ctn biology. These investigations, which also included 
the generation of different animal models, showed that 
p120ctn is indispensable for normal vertebrate development 
(Section 8), and that its deregulation is common in cancer 
(Section 9). Other members of the p120ctn family are also 
involved in various diseases.  
 
3. A MULTITUDE OF P120CTN ISOFORMS 
 
p120ctn is ubiquitously expressed during 
development and in adult organisms, except for several 
non-adherent hematopoetic cell lines and loosely organized 
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Figure 2. Overview of the p120ctn protein. Features include structural and functional domains, as well as a selection of 
alternative splice forms (see text for appropriate references). The p120ctn domains for binding different interaction partners are 
shown at the top. Some of these interactions will be reviewed elsewhere (Pieters et al., in preparation). p120ctn contains two 
conventional nuclear localization signals (NLS) and a nuclear export sequence (NES), but Armadillo repeats (ARM) 3, 5 and 8 
have also been implicated in nuclear trafficking. Due to alternative splicing, four translation start sites (1 to 4) can be used. 
Alternatively spliced internal exons A, B and C, encoding 21, 29 and 6 amino acid residues (AA), respectively, can be included, 
whereas exon D (encoding 24 AA) is rarely spliced out. p120ctn isoform 1ABC is the longest isoform, employs the first start 
codon, and contains all alternatively spliced exons. Numbered blue boxes refer to consecutive ARM repeats. CC, coiled coil 
domain; CTR, C-terminal (non-Armadillo) region; NTR, N-terminal (non-Armadillo) region; PD, phosphorylation domain, 
comprising many Ser, Thr and Tyr residues that are phosphorylated under particular conditions; RBD, RhoA-binding domain. 
 
SW48 colon carcinoma cells, which exhibit very weak 
p120ctn expression (14, 15). Different p120ctn isoforms 
were expressed heterogeneously in normal cell lines and in 
tumor cell lines (3, 14, 16). In 1998, the human p120ctn 
gene (CTNND1), situated on chromosome 11q11, was 
cloned, and inter- and intra-exonic splicing events 
generated multiple p120ctn mRNA variants encoding 
different isoforms (6). Forty-eight putative p120ctn 
isoforms were generated by employing four different 
translation initiation sites (M1-4) combined with four 
alternatively spliced exons (A to D; Figure 2) (6, 17). 
p120ctn 1ABC is the longest isoform, with 968 amino acid 
residues (AA), contains all the alternatively spliced internal 
exons, and is translated from the first start codon to 
produce a protein with the longest N-terminal domain 
(Figure 2). p120ctn isoform 3 has a shorter N-terminal 
domain missing 100 AA that contain a coiled-coil domain, 
whereas p120ctn isoform 4 lacks almost the entire N-
terminal domain in front of the Armadillo repeat domain, 
including the phosphorylation domain (PD) containing 
most phosphorylation sites of p120ctn. The central 
Armadillo repeat domain has nine Armadillo repeats (not 
ten as was previously proposed), with each repeat 
consisting of three helices (18, 19). This Armadillo repeat 
domain is not much affected by alternative splicing. Only 
the six AA encoded by the alternatively spliced exon C are 
situated in the insert loop between Armadillo repeat ARM5 
and ARM6, but this probably does not cause 
conformational changes in the overall structure of the 
Armadillo repeat domain (18, 19). In retrospect, the four 
p120ctn isoforms identified by Reynolds et al. (3) were the 
long isoforms 1N and 1A and the short isoforms 3N and 
3A, with additional internal AA being encoded by the 
alternatively spliced exon A. 
 
p120ctn isoform 1 (120 kDa or long isoform) and 
p120ctn isoform 3 (100 kDa or short isoform) display 
tissue-specific and cell-specific expression patterns. Long 
p120ctn isoform 1 is predominantly expressed in highly 
motile cells, such as fibroblasts and macrophages (3, 14, 
20). In normal tissues, long p120ctn isoforms are 
predominantly expressed in the central and peripheral 
nervous systems, heart, spleen, testis, ovary and endothelial 
cells (17, 21, 22). In contrast, p120ctn isoform 3 is 
P120ctn in development and disease 
abundant in epithelial cell lines (3, 14, 20) and epithelial 
structures of the skin and the gastro-intestinal lining, which 
have a rapid turnover, as well as in kidney, liver, pancreas, 
mammary gland and prostate (6, 17, 21, 22). These cells 
and tissues show bias for expression of certain p120ctn 
isoforms, but most cells and tissues express both long and 
short isoforms. Interestingly, a switch from short to long 
p120ctn isoforms is seen during epithelial-to-mesenchymal 
transition (EMT), which is induced by expression of c-Fos 
(23), Snail (24), SIP1/ZEB2 (25, 26), E47 (26), Slug (26) 
or Twist (27) (see Section 9.2. for more details). 
 
The transcript diversity of p120ctn is increased 
by alternative splicing of internal exons. Exon A encodes a 
21-AA sequence that is ubiquitously expressed in various 
human and murine cell lines and tissues (Figure 2) (6). 
Exon B encodes a putative nuclear export signal (NES) 
with a characteristic leucine motif that counteracts the 
nuclear localization of p120ctn isoform 3A (28). Exon C 
encodes six AA that interrupt the second nuclear 
localization signal (NLS2) of p120ctn, which coincides 
with the second RhoA-binding domain (RBD2) (Figure 2). 
Expression of exon C blocks nuclear localization and 
inhibits 'dendritic-like branching' (Pieters et al., in 
preparation). Exon C is strongly expressed in brain (6) 
(Pieters et al., in preparation). A rare deletion of a fourth 
alternatively spliced internal exon, exon D, was reported in 
fetal and adult brain tissue (17). In conclusion, alternative 
exon usage regulates the subcellular localization of p120ctn 
isoforms and therefore directs their functionality. 
 
4. THE P120CTN GENE FAMILY 
 
The Armadillo catenin family consists of three 
subfamilies: the p120ctn subfamily (p120ctn, ARVCF, 
p0071 and delta-catenin), the plakophilin subfamily 
(plakophilins 1 to 3) and the beta-catenin subfamily (beta-
catenin and plakoglobin) (7, 29) (Figure 3). The p120ctn 
subfamily members associate with cadherins to form proper 
adherens junctions, while members of the plakophilin 
subfamily support desmosomal adhesion. The beta-catenin 
and plakophilin subfamilies have been extensively 
reviewed elsewhere (30-32).  
 
Invertebrates, such as Caenorhabditis elegans 
and Drosophila melanogaster, have only a few catenin 
genes. Only one beta-catenin and one p120ctn ancestor 
have been identified in Drosophila, whereas C. elegans 
contains four highly divergent beta-catenins and only one 
p120ctn subfamily member (33-36). Interestingly, sequence 
analysis revealed that invertebrate p120ctn resembles most 
the vertebrate delta-catenins but not p120ctn (8). In 
vertebrates and particularly in mammals, the diversity of 
the p120ctn family has increased throughout evolution. 
This has led to the emergence of two evolutionarily 
conserved clusters: the p120ctn and ARVCF branch, and 
the p0071 and delta-catenin branch (8) (Figure 3). 
 
All p120ctn family members have similar overall 
structures, with a central domain containing nine Armadillo 
repeats (Figure 4) (18, 19). This Armadillo repeat domain 
enables all p120ctn subfamily members to bind the 
juxtamembrane domain (JMD) of classical cadherins (37-
42). When ARVCF and delta-catenin are overexpressed, 
they can compete with p120ctn for JMD binding (38, 43) 
and they can restore cadherin-based junctions in p120ctn-
depleted cells (44). At endogenous levels, however, 
apparently none of them can substitute for p120ctn. Indeed, 
endogenous ARVCF and delta-catenin fail to stabilize 
classical cadherins in tissue-specific p120ctn knock-out 
mice (45-47).  
 
ARVCF was identified as an Armadillo repeat 
gene that is consistently deleted in velo-cardio-facial 
syndrome patients with interstitial deletions in chromosome 
22q11 (39). It encodes 962 AA and is most closely related 
to p120ctn (Figure 3). Like p120ctn, ARVCF is 
ubiquitously expressed in different tissues but is much less 
abundant (38). Also like p120ctn, ARVCF localizes to the 
nucleus in some cell types (38). Multiple isoforms of 
Xenopus ARVCF are generated by the use of two different 
translation initiation sites and three alternatively spliced 
inserts of 15, 18 and 117 bp (41) (Figure 4). An 18-bp 
insert is also found in human ARVCF (39) and corresponds 
to p120ctn exon C (6). Exon C of Xenopus ARVCF is 
expressed most strongly in brain (41). Human ARVCF too 
is expressed as multiple isoforms, which points to extensive 
alternative splicing like that observed for p120ctn (38). 
 
 The p0071 protein, encoded by the PKP4/Pkp4 
gene, is officially known as plakophilin-4, but this is a 
misnomer because it is more homologous to delta-catenin 
and p120ctn than to any of the genuine plakophilins (Pkp-1 
to -3) (Figure 3). The p0071/Pkp4 protein is ubiquitously 
expressed and localizes in adherens junctions by means of 
its central Armadillo repeat domain, and in desmosomes by 
virtue of its N-terminus (37, 48). However, using novel 
antibodies, Hofmann et al. (49) localized p0071 in non-
desmosomal adherens junctions but not in desmosomes of 
MCF-7 human breast carcinoma cells, human skeletal 
muscle and lung epithelium, and bovine pancreas, tongue, 
thymus and lymphatics. In addition, p0071 is targeted to 
the midbody by the kinesin-II family member, KIF3, but it 
is also located at the centrosomes and spindle bodies of 
mitotic cells, and at composite junctions (areae 
compositae) of the intercalated disks of cardiomyocytes 
(49-51). Two splice variants of p0071 have been reported 
(48). The long variant (encoding a protein of 1211 AA) was 
detected as a major isoform in brain. It is larger than 
p120ctn (981 AA) because of longer N- and C-terminal 
domains (Figure 4). A shorter variant was found to be 
predominant in A431 and HeLa cells (48), and lacks an 
internal stretch of 43 AA in the C-terminal domain.  
 
Delta-catenin was discovered as a presenilin-1-
binding protein (52). It is expressed almost exclusively in 
the nervous system (52-55). The human and mouse delta-
catenins encompass 1225 and 1247 AA, respectively, and 
the mouse delta-catenin has a 25-AA insert in Armadillo 
repeat 7 (new nomenclature based on 18, 19) possibly due 
to alternative splicing (Figure 4) (40, 56). The insert loop of 
delta-catenin contains a polylysine stretch similar to the 
NLS2 of p120ctn (Figure 2) (40). Four translation initiation 
sites have been identified in Xenopus delta-catenin in 
P120ctn in development and disease 
 
 
Figure 3. Phylogenetic tree of p120ctn and plakophilin Armadillo subfamilies. The p120 subfamily consists of p120ctn 
(CTNND1), ARVCF, delta-catenin (CTNND2 or NPRAP) and p0071 (PKP4). The plakophilin subfamily consist of plakophilin 1 
(PKP1), plakophilin 2 (PKP2) and plakophilin 3 (PKP3). The family members from man (Hs), mouse (Mm) and Xenopus 
tropicalis (Xt) are shown. The homologs in fruit fly (Dmp120ctn) and roundworm (CeJAC-1) are grouped in a separate branch 
between the subfamilies. Protein sequences of the central Armadillo repeat domains were aligned using ClustalX2 (189) and a 
Neighbor-Joining tree was constructed with 1000 bootstrap replicates. The tree was visualized with Dendroscope (190) as a radial 
cladogram. 
 
combination with three alternatively used internal sequence 
elements (A-C) (Figure 4) (57). In vitro, several tyrosine 
residues in the N-terminal domain of delta-catenin can be 
phosphorylated by the tyrosine kinase Abl (58) and by Src 
family members (59). 
 
5. P120CTN AND E-CADHERIN REGULATION  
 
5.1. p120ctn interacts with cadherins and modulates 
adherens junctions 
The role of p120ctn in regulating cadherin 
stability and turnover has been studied intensively (60-64). 
In vertebrates, the Armadillo repeat domain of p120ctn 
interacts with the JMD of E-cadherin. p120ctn, E-cadherin, 
beta-catenin and alpha-E-catenin together make up the 
adherens junction complex (Figure 1) (3, 42). Armadillo 
repeats 1 to 5 of p120ctn are essential for its interaction 
with E-cadherin (15, 19), and the exact stoichiometry of the 
cadherin-catenin complex has been determined (16, 20, 65). 
Interestingly, both long and short p120ctn isoforms 
(isoforms 1 and 3, respectively) can bind E-cadherin but 
they cannot bind each other in a higher order molecular 
complex (20). Cadherin-binding is essential for the 
membrane localization of p120ctn: introducing exogenous 
E-cadherin in E-cadherin-negative cells relocalized p120ctn 
from the cytoplasm to the membrane (66). Minimal 
P120ctn in development and disease 
 
 
Figure 4. Overview of isoforms of p120ctn subfamily members. Yellow triangles indicate sequences encoded by alternatively 
spliced internal exons. For alternatively used 5' exons, the multiple possible translation start sites are indicated. Armadillo repeats 
are represented by blue boxes. The sizes of the longest protein isoforms of each family member are indicated on the right. AA: 
amino acid residues. 
 
mutations in the JMD selectively uncoupled p120ctn from 
E-cadherin, disabled p120ctn phosphorylation, and 
interfered with cell-cell adhesion (66).  
 
In contrast to this evidence for a p120ctn 
supportive role in cadherin-mediated adhesion (see also 
Sections 5.2 and 5.3), two reports postulated p120ctn as a 
negative regulator of cadherin function (67, 68). Although 
differential phosphorylation or another biochemical 
modification was proposed as a probable explanation for 
this discrepancy (67, 68), differential expression of p120ctn 
isoforms might also explain why p120ctn can act both as a 
positive and a negative regulator. In both instances in 
which p120ctn acted as a negative regulator, the authors 
used a ‘mesenchymal’ p120ctn isoform 1 construct, which 
is predominantly expressed in non-epithelial cell types, in 
order to induce cell-cell adhesion. Colo-205 cells express 
only p120ctn isoform 1 (67). A better option would have 
been to co-transfect a construct encoding the ‘epithelial’ 
p120ctn isoform 3 with E-cadherin cDNA. Expressing 
p120ctn isoform 1 in E-cadherin-deficient mouse 
fibroblastic L-cells probably stabilizes their mesenchymal 
phenotype rather than transforming it to an adherent one.  
 
5.2. p120ctn regulates cadherin turnover: evidence from 
genetic and knockdown studies 
The positive regulatory effect of p120ctn on 
cadherin expression levels was further underscored in 
several studies using RNAi-mediated depletion of p120ctn 
in cells or genetic depletion in mice. The first clue that 
p120ctn is critical for cadherin function emerged from 
analysis of SW48 colon carcinoma cells bearing mutations 
in the p120ctn gene (15). Due to p120ctn insufficiency, 
these poorly differentiated cells failed to form compact 
colonies and displayed less E-cadherin protein but not 
reduced E-cadherin mRNA (15). The epithelial 
morphology and the cadherin levels could be restored by 
expressing p120ctn isoform 1, 3 or 4, or by using a RhoA-
uncoupled variant of p120ctn isoform 1 (delta622-628), but 
not by using an E-cadherin-uncoupled p120ctn mutant. 
Pulse-chase experiments revealed that p120ctn expression 
increased the E-cadherin half-life (15).  
 
Stable RNAi-mediated knockdown of p120ctn in 
mammalian cells resulted in a drastic and dose-dependent 
decrease in classical cadherins, such as E-, P-, and VE-
cadherin (44, 69, 70), and including mesenchymal 
cadherins, such as N-cadherin and cadherin-11 (71). 
Furthermore, the absence of p120ctn also resulted in 
decreased expression of beta- and alpha-E-catenin due to 
decreased cadherin levels (44, 69). Human cells depleted of 
p120ctn became dispersed, but introduction of a murine 
p120ctn cDNA rescued both morphology and cadherin 
levels (44). Cadherin chimeras, consisting of the 
extracellular domain of interleukin-2 receptor and a 
cytoplasmatic tail of VE-cadherin that still binds p120ctn, 
P120ctn in development and disease 
reduce endogenous VE-cadherin levels due to increased 
internalization of cell surface VE-cadherin, whereas 
p120ctn-uncoupled variants of such chimeras do not have 
such an effect (70). 
 
In Drosophila melanogaster and Caenorhabditis 
elegans, p120ctn is dispensable for the formation of 
cadherin-based junctions and exerts a merely supportive 
role (34, 35, 72). In contrast, p120ctn has been shown to 
stabilize cadherin levels in vivo both in amphibians and in 
mammals. Knockdown of p120ctn (73, 74) or of its family 
members ARVCF (74) or delta-catenin (57) in Xenopus 
embryos reduces the levels of classical cadherins. 
Moreover, gastrulation defects seen upon depletion of 
p120ctn or delta-catenin in Xenopus could be rescued by 
ectopic expression of C-cadherin (57, 74). Tissue-specific 
p120ctn depletion in mice decreases levels of E-cadherin 
(45-47, 75), N-cadherin (75-77), P-cadherin (46) and VE-
cadherin (77). In conclusion, p120ctn regulates cadherin 
turnover at the cell membrane both in vitro and in vivo. 
 
5.3. p120ctn and cadherin biogenesis, endocytosis and 
degradation 
How does p120ctn regulate cadherin trafficking? 
Cadherin-based junctions are highly dynamic, and cadherin 
complexes are constantly assembled and disassembled. The 
process of cadherin trafficking involves cadherin synthesis 
in the Golgi, transport to the cell surface, stabilization at the 
cell surface, or internalization followed by recycling or 
degradation (Figure 1) (78, 79). When newly synthesized 
E-cadherin is transported from the Golgi complex to the 
plasma membrane, its basolateral targeting depends on a 
membrane-proximal dileucine motif in the cadherin tail and 
on its association with beta-catenin (80, 81). Unlike beta-
catenin, p120ctn does not interact with E-cadherin during 
its biogenesis (82), and p120ctn-uncoupled E-cadherin is 
indeed properly targeted to the plasma membrane (66). In 
contrast, p120ctn has been reported to associate with N-
cadherin early during its biogenesis (83), and both N-
cadherin and p120ctn move along microtubule tracks 
towards cell-cell contacts (84, 85). p120ctn isoform 1 
colocalizes and interacts with microtubules and the motor 
protein kinesin, which transports cargos towards the plus 
ends of microtubules nearby the plasma membrane (85-87). 
The N-terminus of p120ctn binds to the heavy chain of 
kinesin, but an N-terminal deletion mutant and native 
p120ctn isoform 4 do not bind kinesin (85, 86, 88). p120ctn 
isoform 1, which contains the entire N-terminal domain, 
binds to kinesin with a higher affinity than p120ctn isoform 
3, which lacks 100 AA of the N-terminus (86). p120ctn 
might therefore play a role in delivering N-cadherins to the 
plasma membrane, and disassembly of the N-
cadherin/p120ctn/kinesin complex indeed delayed the 
delivery of N-cadherin to cell-cell contacts (85). In 
contrast, delivery of newly synthesized E-cadherin to the 
plasma membrane was not delayed by depletion p120ctn 
(44). 
 
Interestingly, a recent study revealed the 
interaction of the N-terminal domain of p120ctn with 
PLEKHA7 (pleckstrin homology domain-containing, 
family A member 7) (89). In the zonula adherens of 
polarized epithelial cells, a p120ctn-PLEKHA7-Nezha 
chain forms a bridge between the cadherin-catenin complex 
and the minus ends of microtubuli. The integrity of the 
zonula adherens is clearly dependent on this 
macromolecular complex and a possible underlying 
mechanism is the recruitment via this complex of the 
minus-end directed motor KIFC3 (89). As the cell surface 
expression of E-cadherin was not reduced by depletion of 
PLEKHA7, Nezha or KIFC3, this could indicate that 
p120ctn and associated proteins stabilize the minus ends of 
noncentrosomal microtubules, in line with previously 
reported stabilization of these ends by cadherin-mediated 
junctions (90). 
 
Cell surface cadherins can be internalized via 
different pathways, including clathrin-dependent 
endocytosis (91-95), caveola-mediated endocytosis (96, 
97), lipid-raft-mediated endocytosis (98, 99) and 
micropinocytosis (100, 101). The decision to enter a certain 
endocytotic pathway is highly cell-specific and depends on 
the microenvironment. Once internalized, cadherins can be 
recycled back to the plasma membrane or targeted for 
proteasomal or lysosomal degradation. p120ctn blocks 
clathrin-mediated endocytosis of VE-cadherin, and this 
inhibition depends on the binding of p120ctn to the JMD of 
VE-cadherin (93). On the other hand, increased E-cadherin 
endocytosis was observed in cells expressing a p120ctn-
uncoupled E-cadherin mutant as well as in cells in which 
p120ctn was depleted by RNAi (102). It is not clear how 
p120ctn prevents endocytosis, but several possibilities have 
been proposed. First, a dileucine motif in the cytoplasmic 
tail of E-cadherin (close to the JMD) is responsible for 
clathrin-mediated internalization of E-cadherin (102). If the 
dileucine motif is mutated or if the cadherin tail is 
completely deleted, E-cadherin fails to undergo endocytosis 
(102, 103). p120ctn might regulate E-cadherin endocytosis 
by masking the dileucine motif to prevent its interaction 
with adaptor proteins, such as AP-2, which are required for 
clathrin-mediated endocytosis (104). Second, p120ctn 
seems to compete with presenilin-1 and Hakai for binding 
to the JMD of classic cadherins. Presenilin-1 favors E-
cadherin degradation by proteolytic cleavage of the 
cadherin cytoplasmic tail (105, 106). Although, during 
synapse maturation, p120ctn dissociates from another 
classical cadherin, N-cadherin, and is replaced by 
presenilin-1 (107). Hakai is an E3 ubiquitin ligase and 
binds to the phosphorylated tyrosine motifs in the JMD of 
E-cadherin (but it does not bind other classical cadherins). 
(108, 109) This leads to ubiquitination and endocytosis of 
E-cadherin (Figure 1) (see also Section 6). To conclude, 
p120ctn seems to act as a cap that binds cadherin and 
prevents its endocytosis. In the light of this, one may expect 
p120ctn defects to have major pathological effects. 
 
6. P120CTN AND SIGNALING IN THE CYTOPLASM 
 
The early hints about the role of cytoplasmic 
p120ctn came from p120ctn overexpression studies. 
Expressing large amounts of exogenous p120ctn protein 
saturated cadherin-binding sites, and the excess of p120ctn 
translocated to the cytoplasm and caused a neuron-like 
cellular morphology, i.e. outgrowth of extensions similar to 
P120ctn in development and disease 
dendritic branching (9). This phenotype was due to 
p120ctn-mediated RhoA inhibition, as the phenotype could 
be mimicked by adding a RhoA inhibitor (C3 
exotransferase) or by expressing p190RhoGAP (10, 110). 
Also, this dendritic-like branching could be blocked by 
coexpressing a constitutively active (CA) RhoA variant 
(10-12). An N-terminal deletion that includes RBD1 
diminishes p120ctn-induced branching (111), but branching 
is completely blocked by deleting a second RBD 
(containing AA 622-628; Figure 2) (10). Is this branching 
phenotype RhoA-specific? Or are there other RhoGTPases 
involved? Also, activation of Rac1 and Cdc42 might 
influence p120ctn-mediated branching because in two 
studies branching was blocked by dominant negative forms 
of Rac1 and Cdc42 (11, 12). Moreover, p120ctn binds to 
Vav2, a specific guanine nucleotide exchange factor for 
RhoGTPases, and overexpression of a dominant-negative 
Vav2 construct decreased p120ctn-induced 'dendritic-like 
branching' (12). Overall, p120ctn regulates RhoGTPase 
activity by inhibiting RhoA and by activating Rac1 and 
Cdc42, and this alters cytoskeletal dynamics and increases 
cell migration (12). However, this 'simple' hypothesis was 
not confirmed in all other studies and the current idea is 
that Rho-GTPase family members are differentially 
regulated by various p120ctn isoforms in a complex and 
sometimes antagonistic way that depends much on the 
micro- and macro-environments (69, 110, 112) (Patrick 
Derksen, personal communication) (Pieters et al., in 
preparation). The contextual signals involved are diverse 
and include growth factor signaling, cell-cell interactions, 
cell-matrix interactions, and surface tension. 
 
Do cadherins modulate p120ctn-mediated 
cytoplasmic signaling? Dendritic-like branching could be 
blocked by sequestering overexpressed p120ctn by co-
expression of E- or C-cadherin (10, 12). Such inhibition 
was possible by either the complete transmembrane domain 
of E- or C-cadherin or by its JMD only, but not by its beta-
catenin binding domain CBD only (10, 12). On the other 
hand, E-cadherin binding is dispensable for this p120ctn-
induced branching because E-cadherin-uncoupled p120ctn 
mutants lacking either Armadillo repeat 1 (ARM1) or 
Armadillo repeats 1-3 (ARM1-3) can still elicit a branched 
morphology (9, 71). Like cadherins, microtubules can 
tether p120ctn away from cytoplasmic pools and thereby 
prevent p120ctn-induced dendritic-like branching. 
Coexpression of the kinesin heavy chain reduced the 
branching elicited by p120ctn isoform 1 but not that 
elicited by p120ctn isoform 3, which means that isoform 1 
has a higher affinity for kinesin (86).  
 
Also phosphorylation of p120ctn turned out to be 
important for cytoplasmic signaling, including the 
dendritic-like branching induced by p120 overexpression. 
The majority of phosphorylation sites, as well Ser as Thr 
and Tyr residues, are located in the phosphorylation 
domain (PD), which is situated in the N-terminus of 
p120ctn (Figure 2). Deleting either the entire N-terminus of 
p120ctn (mimicking p120ctn isoform 4) or only its 
embedded phosphorylation domain prevents dendritic-like 
branching, whereas p120ctn mutants lacking only part of 
the phosphorylation domain can still elicit branching (9, 11, 
111). Further, several Tyr residues in the first RBD of 
p120ctn have been shown to affect the affinity between 
p120ctn and RhoA (113). The following questions 
therefore emerge: how does protein phosphorylation affect 
cadherin-based adhesion in general? Which kinases and 
phosphatases are involved, either directly or indirectly? 
Which phosphorylation sites in p120ctn play which roles? 
These issues will be reviewed in depth elsewhere (Pieters et 
al., in preparation). Generally speaking, most studies on 
posttranslational modifications of cadherin-catenin 
complexes deal with tyrosine-specific phosphorylation 
executed by either receptor tyrosine kinases (RTKs) or non-
receptor tyrosine kinases (nRTK). On the other hand, 
protein tyrosine phosphatases (PTPs) reverse this 
phosphorylation and allow dynamic protein modification in 
response to internal and external cues (reviewed in 114). 
The presence of multiple phosphorylation sites in cadherins 
and catenins and the multitude of different kinases and 
phosphatases located at the membrane increase the 
potential for modulating cell-cell adhesive strength. The 
underlying mechanisms are, however, not fully clear, and 
there is evidence for both a positive role and a negative role 
for tyrosine phosphorylation. One way to investigate the 
phosphorylation of cadherin-catenin structures is by using 
Src-mediated cellular transformation, which leads to 
constitutive phosphorylation on Tyr of all membrane-bound 
Src substrates, including cadherins and catenins.  
 
Indeed, the p120ctn protein was originally 
identified as a most efficient substrate for the nRTK Src 
and for several RTKs (1, 2). How does tyrosine 
phosphorylation of p120ctn affect cadherin-based 
adhesion? In Src-transformed MDCK and L-cells, 
constitutive tyrosine phosphorylation of p120ctn and beta-
catenin is associated with weakening of the cadherin-based 
junctions (115, 116). This p120ctn phosphorylation is 
dependent on E-cadherin association. In contrast, the 
presence of cadherin-bound beta-catenin is not essential for 
Tyr phosphorylation of p120ctn, as an E-cadherin–alpha-
catenin fusion is equally potent in phosphorylating p120ctn 
junctions (115, 116). Also inducible expression of the 
nRTK Fer in embryonic fibroblasts disrupts their adherens 
junctions, apparently due to diminished levels of cadherin-
bound alpha- and beta-catenins (117). Treatment of 
SKOV3 ovarian cancer cells with lysophosphatidic acid 
(LPA) increases the association of nRTK Fyn with p120ctn 
at cell-cell junctions, activation of Fyn, and intercellular 
junction dispersal (118). Knockdown of Fyn prevented this 
LPA-induced cell dispersal. So, forced tyrosine 
phosphorylation of mature confluent cell layers causes cell 
dispersal. The reverse is also true, because in human 
endothelial cells, p120 is transiently Tyr-phosphorylated in 
nascent cell-cell contacts, but this phosphorylation is lost in 
stable confluent layers (119). Loose cells might be more 
accessible for growth factors and therefore show an 
increased phosphotyrosine status. Nonetheless, it is not 
clear how Tyr phosphorylation of p120ctn affects its 
binding to E-cadherin. Several groups reported that tyrosine 
phosphorylation of p120ctn increases its binding affinity 
for E-cadherin (117, 120-123), while others found no 
change in binding affinity between E-cadherin and p120ctn 
upon Src-mediated phosphorylation (3, 116). Finally, an 
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acidic extracellular pH activated c-Src and Fyn kinases in 
HepG2 cells, resulting in Tyr phosphorylation of p120ctn 
and E-cadherin, and apparently a decreased association 
between p120ctn and E-cadherin (124). Because the 
binding domain of p120ctn in the E-cadherin cytoplasmic 
tail encompass Tyr residues, which upon phosphorylation 
recruit the E3 ubiqutin ligase Hakai, decreased p120ctn 
binding facilitates the action of Hakai and results in 
ubiquitination and endocytosis of E-cadherin. 
 
A phosphorylation-dependent electrophoretic 
mobility shift of p120ctn is seen in the case of E-cadherin 
induction in transduced MDA-MB231 cells, and this shift 
was ascribed to Ser/Thr phosphorylation (66). Interestingly, 
induction of p120ctn-uncoupled E-cadherin mutants was 
unable to induce this shift, which indicates that E-cadherin 
binding is necessary also for Ser/Thr phosphorylation of 
p120ctn. On the other hand, Ser/Thr phosphorylation of 
p120ctn does not affect the p120ctn–cadherin binding 
affinity or the cadherin complex stability. Indeed, mutating 
either individual Ser or Thr phosphorylation sites to Ala or 
mutating six major Ser/Thr sites together to Ala does not 
interfere with the capacity of mutated p120ctn to rescue the 
phenotypes of p120ctn-deficient cells (125). In conclusion, 
increased Tyr phosphorylation of p120ctn disrupts adherens 
junctions, while constitutive Ser/Thr phosphorylation of 
p120ctn does not affect their integrity. 
 
7. P120CTN AND TRANSCRIPTION FACTOR 
SIGNALING 
 
 Like beta-catenin, p120ctn acts both as a 
component of adherens junctions and as a transcriptional 
regulator in the nucleus. p120ctn in the nucleus (28, 87, 
111, 126, 127) interacts with transcription factors Kaiso 
(13) and Glis2 (128). Interestingly, Kaiso coprecipitates 
efficiently with p120ctn isoform 3 in epithelial lines, but 
not with p120ctn isoform 1 in fibroblasts (13). Nuclear 
trafficking of p120ctn depends on conventional NLS and 
NES signals (Figure 2) (28, 111, 126), as well as on its 
Armadillo repeat domain (87) and on the 
microenvironment (129). Kaiso also contains a functional 
NLS for its nuclear import (130). In addition, recent reports 
point at interesting interactions between the Wnt signaling 
pathway and p120ctn in the cell junctions or the cytoplasm 
(131-133). 
 
p120ctn and its relation to the transcription factor 
Kaiso have been studied extensively (134-136). The 
Armadillo repeat domain of p120ctn binds to the C-
terminal zinc finger domain of Kaiso and thereby inhibits 
the interaction between this zinc finger domain and DNA 
(13). Kaiso has a dual specificity for DNA: it can bind to 
sequence-specific Kaiso binding sites (KBS) and to 
methylated CpG-dinucleotides (137, 138). Remarkably, the 
function of Kaiso that involves binding to sequence-
specific KBSs is dispensable in vivo (139). The binding of 
Kaiso to methylated DNA is evolutionarily conserved (139) 
and allows histone-deacetylase-dependent transcriptional 
repression. This involves the recruitment of chromatin co-
repressor components, such as nuclear co-repressor 1 
(NCOR) (140), to the N-terminal poxvirus and zinc finger 
(POZ) domain of Kaiso. The POZ domain also enables 
Kaiso to homodimerize (13, 141). Kaiso acts as a 
transcriptional repressor and p120ctn can bind to Kaiso and 
block its repressor activity, resulting in activation of the 
target genes of Kaiso, such as Siamois, c-Fos, Myc, Ccnd1 
(encodes Cyclin D1) (142), xWnt11 (143), and Mmp7 
(encodes Matrilysin) (144). There is significant overlap 
between the target genes of p120ctn/Kaiso and the beta-
catenin/TCF signaling pathways. The synergism between 
these pathways was observed both in cell lines (144) and in 
Xenopus embryos (142). The promoter of the matrilysin 
gene contains two KBSs, and Kaiso can repress beta-
catenin-induced activation of the Mmp7 gene, but this 
Kaiso-mediated transcriptional repression of Mmp7 can be 
reversed by p120ctn expression (144). Several other beta-
catenin target genes contain KBSs, and in Xenopus 
embryos they can be either repressed by Kaiso or activated 
by either beta-catenin activity or Kaiso depletion (142). 
The strongest transcriptional activation of Siamois was 
obtained by beta-catenin expression in Kaiso-depleted 
Xenopus embryos (142). p120ctn relieves the Kaiso-
mediated repression of beta-catenin target genes, and its 
ablation in Xenopus embryos increases the repression of 
these genes (142). Frodo physically links the p120ctn/Kaiso 
and beta-catenin/TCF pathways by binding to both p120ctn 
and Dishevelled (131). Frodo acts upstream of both 
signaling pathways and stabilizes p120ctn, which relieves 
Kaiso-mediated transcriptional repression of beta-catenin 
target genes (131). An additional link between 
p120ctn/Kaiso and the beta-catenin/TCF pathways is 
provided by the interaction between Kaiso and TCF3 in 
Xenopus (145). Although Kaiso acts as a genome wide 
transcriptional repressor in Xenopus embryos (146), no 
increased gene expression was observed in Kaiso-deficient 
mice (147). Morpholino-mediated depletion of Kaiso in 
Xenopus embryos results in severe defects in gastrulation 
and in convergent extension, and these phenotypes can be 
rescued by re-expression of Kaiso (142, 143). In contrast, 
Kaiso-deficient mice are viable (147). The discrepancy 
between the findings in mice and in Xenopus concerning 
the developmental requirement for Kaiso and its gene 
regulatory activity might be explained by functional 
redundancy of Kaiso-like family members (134). Indeed, 
Kaiso is part of a small protein family that contains two 
other Kaiso-like proteins, namely ZBTB4 (Kaiso-like 1) 
and ZBTB38 (ZENON). Like Kaiso, these proteins bind 
methylated DNA and act as transcriptional repressors 
(148). Like Kaiso, ZBTB4 exerts bimodal DNA binding, 
whereas ZBTB38 binds only methylated DNA (148). 
ZBTB4 has been implicated in p53 activation (149). 
Interestingly, no ZBTB4 homolog could be identified in 
Xenopus, which indicates that ZBTB4 might substitute for 
Kaiso in mouse but not in frog. 
 
It was generally assumed that the stability of the 
ubiquitously expressed p120ctn was regulated differently 
from that of cytoplasmic beta-catenin. Beta-catenin is well 
known to be subject to association with axin and APC 
proteins, to phosphorylation by kinases of the CK1 family 
and by GSK3-beta, eventually followed by ubiquitination 
and proteasomal degradation. The McCrea group recently 
reported that specifically the long isoform-1 of p120ctn can 
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associate with CK1-alpha and GSK3-beta, and that it is 
prone to phosphorylation by these kinases, as well as to 
axin binding, ubiquitination and proteasomal degradation 
(133). A quadruple point mutation, converting four Ser 
residues at the N-terminus of Xenopus p120ctn into Ala 
residues, protects against this molecular destruction 
complex and efficiently relieves Kaiso-mediated repression 
of the Wnt target genes, Wnt11 and xSiamois. Moreover, 
the related Armadillo subfamily members ARVCF and 
delta-catenin of Xenopus bind likewise to axin and are 
responsive to the axin-containing destruction complex 
(133), in line with a previous report on vulnerability of 
human delta-catenin to GSK3-beta-triggered degradation 
(150).  
 
In another recent report, p120ctn was shown to 
bind to CK1-epsilon via an N-terminal domain (Figure 2) 
(132). This interaction domain is also contained in the 
shorter isoform 3, which is the most abundant isoform in 
epithelial cells. Whereas CK1-alpha is an inhibitor of 
canonical Wnt signaling by virtue of its destabilizing effect 
on cytoplasmic beta-catenin, CK1-epsilon is activated upon 
Wnt triggering and contributes to stabilizing beta-catenin. 
The authors provide evidence that activated CK1-epsilon 
phosphorylates several proteins in a pre-signalosome 
complex comprising p120ctn, E-cadherin, the Wnt 
coreceptor LRP5/6, and the Wnt receptor Fz. This event 
results in recruitment of Dvl, axin and GSK3-beta to the 
signalosome, leading to inactivation of the beta-catenin 
destruction complex, but at the same time, beta-catenin and 
p120ctn/CK1-epsilon dissociate from E-cadherin. 
Dissociated and stabilized beta-catenin promotes TCF-
mediated transcription, whereas dissociation of 
p120ctn/CK1-epsilon might act as a negative feedback to 
halt further Wnt signaling at the receptor level (132). In this 
model, p120ctn functions as an essential but subtle 
regulator of Wnt signaling by recruiting CK1-epsilon to the 
E-cadherin/LRP/Fz receptor complex, and by counteracting 
this phenomenon upon Wnt-induced activation of CK1-
epsilon. 
 
8. THE P120CTN FAMILY IN ANIMAL MODELS 
 
8.1. Animal models for p120ctn 
The knockout and depletion of p120ctn in 
invertebrates (C. elegans and Drosophila), amphibians 
(Xenopus) and mammals (mouse) was recently reviewed 
(8). The only p120ctn subfamily members in C. elegans 
and Drosophila are CeJAC-1 and Dmp120ctn, respectively 
(Figure 3), yet their genetic deletion or RNAi-mediated 
reduction did not affect normal development (Table 1) (34, 
35, 151). In contrast, RNAi depletion of both zygotic and 
maternal p120ctn in Drosophila embryos resulted in severe 
morphogenetic defects, particularly in head involution (33). 
Drosophila p120ctn interacts with DRho1 (the Drosophila 
RhoA homolog) (33), but DRho1 maintains proper 
localization of DE-cadherin and catenins in the absence of 
Dmp120ctn (151). In addition, mutants of Drosophila DE-
cadherin could be rescued by p120ctn-uncoupled DE-
cadherin mutants but not by beta-catenin-uncoupled 
mutants, indicating that p120ctn in invertebrates is not a 
core component of adherens junctions and that it has only a 
supportive role (34, 72). 
 
In contrast, morpholino-mediated p120ctn 
knockdown in Xenopus resulted in severe developmental 
defects; the nature of the defects depended on which cells 
of early cleavage embryos were injected with morpholinos 
(Table 1) (73, 74). On the other hand, induced expression 
of murine p120ctn isoform 1A or 1N during amphibian 
development leads to gastrulation defects and head 
malformation, respectively, in contrast to the secondary 
body axis abnormality caused by overexpression of beta-
catenin (152, 153). So, normal development is contingent 
on maintenance of p120ctn expression levels within a 
physiological range. Total knockout of p120ctn results in 
early death of embryos (mentioned in refs. 45, 76). 
According to a personal communication from Walter 
Birchmeier (Berlin), embryonic death is seen at E10. 
Despite seemingly normal mesoderm formation, embryos 
do not turn at E8.5 to E9. The notochord is interrupted, and 
cell-cell adhesion within the notochord and to the 
endoderm is weakened. Embryos stop growing at the 10-
somite stage and closure of the neural tube is not 
completed. Several tissue-specific p120ctn knockouts have 
been generated by using the Cre/LoxP system. Two types 
of floxed p120ctn alleles were generated. In one of them, 
p120ctn exons 3 to 8, encoding all four possible start 
codons (M1-4), were flanked by LoxP sites to prevent any 
natural initiation of translation after Cre-mediated 
recombination (45). In the other approach, exon 7 of 
p120ctn was floxed, and Cre-mediated recombination 
resulted in a frameshift leading to degradation of mRNA by 
non-sense mediated decay (76). The importance of p120ctn 
during development is further demonstrated by Cre-
mediated ablation of p120ctn in endothelial tissues at 7.5 
dpc, which caused death at 11.5 dpc (77). In other studies, 
developmental defects in tissue-specific p120ctn knockouts 
are mostly avoided by employing mouse lines expressing 
Cre near the end of embryonic development. Nevertheless, 
ablating p120ctn after midgestation in salivary gland and 
intestine can still result in perinatal death (45, 47), whereas 
its ablation in the skin, teeth or dorsal forebrain does not 
affect viability (46, 75, 76). Though these conditional 
p120ctn knockout mice show a wide range of tissue-
specific phenotypes (listed in Table 1) (8), reduction of 
cadherin levels seems to be a common underlying 
mechanism (Section 5.2).  
 
8.2. Animal models for p120ctn family members 
Like p120ctn, ARVCF and delta-catenin are 
essential during Xenopus development. For instance, 
gastrulation defects are caused by generalized or localized 
knockdown of delta-catenin (Table 1) (57, 74). However, 
ARVCF and delta-catenin seem to be dispensable in mice, 
because both ARVCF and delta-catenin knockout mice are 
viable (personal communication by Raju Kucherlapati, 
Boston, MA, and ref. 154). Nevertheless, delta-catenin-
deficient mice display congnitive dysfunctions, including 
severe learning defects, and abnormal synaptic plasticity 
(154). This is in line with the observed hemizygous loss of 
delta-catenin in humans suffering from the Cri du Chat 
syndrome, which is featured by severe mental retardation 
(155).  
Table 1. Knockout and knockdown of p120ctn family members in different species 
Catenin Organism Tissue/cell type 
Knockout (KO) or  
knock down (KD) Phenotype References 
JAC-1 C. elegans whole animal KD (RNAi) No obvious developmental defects (35) 
p120ctn Drosophila whole animal zygotic and maternal KO 
No obvious developmental defects; except delayed dorsal 
closure (34) 
    whole animal KD (RNAi) No obvious developmental defects (151) 
    whole animal 
KO (includes several 
genes) Severe dorsal open phenotype (33) 
    whole animal KD (RNAi) Severe morphogenic effects, including head involution (33) 
    whole animal KO and KD (RNAi) Reduced numbers and density of spine-like neuronal protrusions (191) 
p120ctn Xenopus whole animal KD (Morpholino) 
Disrupted gastrulation and axial elongation; reduced C-cadherin 
levels (74) 
    
anterior neural 
ectoderm KD (Morpholino) 
Impaired evagination of optic vesicles and defective eye 
formation; perturbed cranial neural crest cell; migration and 
malformations in craniofacial cartilage (73) 
p120ctn mouse whole animal KO  Early embryonic death  
(45, 76); 
W.B. 
    salivary gland KO (MMTV-Cre) 
Die shortly after birth; blocked acinar differentiation; reduced E-
cadherin levels; formation of neoplasias; abnormal epithelial 
polarity and morphology  (45) 
    skin KO (K14-Cre) 
Viable; reduced adherens junction components; increased RhoA 
activity; epidermal hyperplasia and chronic inflammation in 
aged mice; NFκB activation; skin neoplasias; mitotic defects (46, 165) 
    teeth KO (K14-Cre) 
Viable; reduced E- and N-cadherin; dysplastic hypo-mineralized 
enamel; disrupted ameloblast polarity and morphology (75) 
    
vascular 
endothelium KO (Tie2-Cre) 
Die at 11.5 dpc; disorganized embryonic and extraembryonic 
vasculature; decreased microvascular density and hemorrhage; 
defective proliferation; reduced VE- and N-cadherin (77) 
    dorsal forebrain KO (Emx1-Cre) 
Viable; reduced spine and synapse densities; decreased N-
cadherin levels; increased RhoA activitiy (76) 
    
small intestine; 
colon KO (Villin-Cre) 
Die within 3 weeks; disruption of epithelial barrier; mucosal 
erosion; reduced adherens junction components; increased 
inflammation and neutrophil binding (47) 
    liver KO (Albumin-Cre) 
Viable; severely impaired intrahepatic bile duct development; 
normal hepatocyte differentiation; unaltered cell-cell adhesion; 
accelerated initiation of hepatocarcinogenesis by 
diethylnitrosamine  
van Hengel et 
al., 
unpublished 
ARVCF Xenopus whole animal KD (Morpholino) 
Disrupted gastrulation and axial elongation; reduced C-cadherin 
levels (74) 
    
anterior neural 
ectoderm KD (Morpholino) 
Perturbed cranial neural crest cell migration; malformations in 
craniofacial cartilage K.V. & M.D. 
  mouse whole animal   Viable; no obvious abnormality R.K.  
delta-
catenin Xenopus 
whole animal; 
anterior neural 
ectoderm KD (Morpholino) 
Defects in gastrulation and axial elongation; reduced cadherin 
levels;  RhoA activation; malformations in eye and craniofacial 
skeleton (57) 
  mouse whole animal KO 
Impaired cognitive functions; abnormal synaptic plasticity; 
reduced N-cadherin and PSD-95 levels (154) 
W.B.: Walter Birchmeier, personal communication; K.V. & M.D.: Kris Vleminckx and Mieke Delvaeye, personal communication; R.K.: Raju 
Kucherlapati, personal communication.  
 
p120ctn can probably substitute for ARVCF and 
delta-catenin in knockout mice, whereas p120ctn family 
members ARVCF, p0071 and delta-catenin cannot rescue 
the lethal phenotypes in p120ctn knock-out mice. This 
further illustrates that ARVCF, p0071 and delta-catenin are 
functionally not fully redundant. Alternatively, ARVCF, 
p0071 and delta-catenin might be intrinsically redundant, 
although they have restricted spatial and temporal 
expression patterns.  
 
9. P120CTN AND CANCER 
 
9.1. Altered expression of p120ctn in tumors 
The role of p120ctn in tumors has been reviewed 
(156, 157). In general, p120ctn is either absent or altered in 
most human tumors, and its derangement is often correlated 
with poor prognosis. Alterations in p120ctn expression 
include decreased levels and translocation to the cytoplasm, 
and occasionally to the nucleus. These alterations remove 
p120ctn from the cell membrane and disable p120ctn-
mediated stabilization of E-cadherin. p120ctn can act as a 
proto-oncogene or as an invasion-suppressor, depending on 
the order in which p120ctn and E-cadherin are down-
regulated. Loss of p120ctn results in decreased E-cadherin 
levels, and E-cadherin is indeed frequently down-regulated 
in epithelial cancers in which it acts as a tumor-suppressor 
(158, 159). On the other hand, E-cadherin loss results in 
translocation of p120ctn to the cytoplasm, where p120ctn 
modulates RhoGTPases in a way that favors cell motility 
(see Sections 6 and 9.5). Like overexpression of dominant 
active Rac1, p120ctn-mediated Rac1 activation might 
promote cellular transformation. p120ctn also acts as a 
proto-oncogene by relieving the Kaiso-mediated repression 
of beta-catenin target genes, such as c-Fos, Myc, Ccnd1 
(encodes Cyclin D1) and Mmp7 (encodes Matrylisin) (142, 
144), and this favors tumor formation and invasion. In 
addition, Kaiso-deficient mice are more resistant to 
intestinal tumorigenesis when bred into an APCMin/+ genetic 
background (147). Heterozygous APCMin mice are used as a 
model for human familial adenomatous polyposis caused 
by a mutation of the Apc gene (adenomatous polyposis 
coli) that leads to nuclear localization of beta-catenin and 
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activation of the canonical Wnt pathway. In contrast to 
tumor-associated nuclear beta-catenin, nuclear localization 
of p120ctn is observed only rarely in human tumors (127, 
160). 
 
Only a few mutations in the CTNND1 gene have 
been reported, in breast cancer (161) and in SW48 colon 
carcinoma cells (15). It is noteworthy that p120ctn 
expression might be compromised by mutating a single 
p120ctn allele. Indeed, expression of p120ctn can be 
monoallelic in some cell types (162). Perhaps other 
mechanisms are involved in p120ctn downregulation in 
tumors, such as transcriptional downregulation, epigenetic 
modification or microRNA-mediated silencing, but this is 
poorly documented. p120ctn is transcriptionally 
downregulated by FOXC2 in non-small cell lung cancer 
cells (NSCLC) (163). FOXC2 binds to the p120ctn 
promoter and reduces its activity. On the other hand, 
RNAi-mediated silencing of FOXC2 increases p120ctn 
promoter activity as well as p120ctn mRNA and protein 
levels. p120ctn stabilizes cadherins at the cell membrane 
and RNAi-mediated depletion of its transcriptional 
repressor, FoxC2, enhances E-cadherin levels in NSCLC 
cells (163). Another intriguing finding is the upregulation 
of non-junctional delta-catenin expression in advanced 
human prostate cancers, which correlates with reduced 
levels or cytoplasmic relocation of both E-cadherin and 
p120ctn (164). The reduced expression of E-cadherin and 
p120ctn at the cell–cell junctions could be reproduced by 
transfecting a prostate cancer cell line with a plasmid 
expressing delta-catenin.  
 
The role of p120ctn in cancer was further 
investigated in animal models. Ablation of p120ctn in 
salivary gland resulted in morphological abnormalities 
closely resembling high-grade intraepithelial neoplasia, a 
precancerous condition in humans that typically progresses 
to invasive cancer (45). Ablation of p120ctn in skin caused 
hyperproliferation (46) and p120ctn-deficient skin grafts 
displayed signs of epidermal hyperkeratosis and dysplastic 
keratinocytes (165). In addition, p120ctn regulates several 
processes involved in tumorigenesis, such as RhoGTPase 
activity, cell proliferation, motility, invasion, anchorage-
independent growth (AIG), and inflammatory conditions 
(see below).  
 
9.2. p120ctn isoforms in EMT and cancer 
Epithelial-to-mesenchymal transition (EMT) is an 
orchestrated series of events that allows epithelial sheets to 
dissociate, lose cell-cell interactions and cell-extracellular 
matrix interactions, and reorganize the cytoskeleton and 
transcriptional program in order to induce a mesenchymal 
phenotype (166). During EMT, E-cadherin downregulation 
in epithelial cells is accompanied by upregulation of 
mesenchymal cadherins (e.g. N-cadherin or cadherin-11), a 
phenomenon called cadherin switching (167). Cadherin 
switching has been observed during normal development, 
such as primitive streak formation and neural crest 
delamination, and also during tumorigenesis (167, 168). 
Interestingly, a switch from short to long p120ctn isoforms 
has been observed during EMT induced by expression of c-
Fos (23), Snail (24), SIP1/ZEB2 (25, 26), E47 (26), Slug 
(26) or Twist (27). The downregulation of short ‘epithelial’ 
p120ctn isoforms during EMT is due to decreased 
expression of epithelial splicing regulatory proteins 1 and 2 
(ESRP1 and ESRP2), which favors skipping of exon 3 
(encoding the first two translation initiation sites) and 
initiation of translation from the third start codon (encoded 
by exon 5) (27). Also Src transformation of MDCK cells 
induces an EMT-like process (169) associated with a 
switch from short to long p120ctn isoforms (14). This 
switch during EMT is consistent with the expression 
pattern of long and short p120ctn isoforms in fibroblasts 
and epithelial cell types, respectively (Section 3). Re-
expression of E-cadherin in Snail-induced mesenchymal 
cells failed to restore the epithelial morphology and 
expression of ‘epithelial’ short p120ctn isoforms (24). This 
confirms that the abundance of the different p120ctn 
isoforms is regulated by cell-type-specific splice factors but 
not necessarily by the expression of certain cadherin types 
(27). In contrast, the p120ctn isoform switch was not 
observed during EMT induced in highly differentiated 
colon cancer cells by TGF-beta and TNF-alpha (170). This 
discrepancy might be explained by the expression of long 
p120ctn isoforms in non-induced cells at levels that cannot 
be augmented even further during EMT. Increased RhoA 
inhibition is observed during EMT induced by TGF-beta 
and TNF-alpha, which coincides with increased binding of 
p120ctn to RhoA (170). 
 
EMT-like processes have been observed during 
progression of prostate carcinoma and in anaplastic thyroid 
carcinomas. These changes coincide with a switch from 
short to long p120ctn isoforms and from E- to N-cadherin 
(171, 172). Forced expression of E-cadherin in the 
pancreatic carcinoma cell line MIA PaCa-2 restored the 
epithelial phenotype and suppressed cell migration and 
invasion, but forced expression of N-cadherin did not have the 
same effect (173). Interestingly, E-cadherin bound 
predominantly to unphosphorylated p120ctn isoform 3 
whereas tyrosine-phosphorylated p120ctn isoform 1 interacted 
exclusively with N-cadherin (173). In skin cancer, p120ctn 
actions and isoform switching are more controversial. 
One RT-PCR study reported predominant expression of 
short p120ctn isoforms both in normal skin tissue and in 
benign and malignant skin cancer cells (160). In 
squamous cell carcinomas (SCCs), the p120ctn levels 
were consistently reduced but E-cadherin levels were 
not. Any remaining p120ctn was detected in the 
cytoplasm and sometimes in the nucleus but not at the 
cell–cell boundaries (160). Another study (111), which 
used antibodies specific for different p120ctn isoforms, 
revealed that neonatal human keratinocytes and HaCaT 
cells (immortalized but non-tumorigenic keratinocytes) 
expressed p120ctn isoforms 2, 3 and 4, whereas SCCs 
expressed predominantly p120ctn isoform 2 but not 
isoforms 3 or 4. Thus, both studies indicate that there is 
no striking difference in expression of p120ctn isoforms 
between benign (immortalized human keratinocytes) and 
malignant epithelial skin tumors (SCCs). On the other 
hand, it was reported that expression of exogenous R-
cadherin in squamous carcinoma cells sequesters p120ctn 
away from endogenous E- and P-cadherin and thereby 
causes downregulation of these cadherins (174). 
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Melanocytes are quite interesting because, unlike 
most epithelial cells, they express the mesenchyme-
associated long p120ctn isoforms in combination with E-
cadherin. This shows that specific p120ctn isoforms are not 
invariably restricted to a certain cadherin type. As both 
keratinocytes and melanocytes express E-cadherin, 
heterotypic interaction by a homophilic adhesion 
mechanism is possible. However, melanomas switch to N-
cadherin during tumorigenesis, and this enables them to 
dissociate from the keratinocyte layers and to interact 
heterotypically with stromal cells, including fibroblasts and 
endothelial cells (175). This tumorigenic conversion is not 
associated with a p120ctn isoform switch as both normal 
melanocytes and melanomas express primarily p120ctn 
isoform 1 (111). In melanomas, p120ctn can compete with 
RhoA for binding to p190RhoGAP, which leads to RhoA 
activation. Reintroducing E-cadherin in melanomas 
blocked chemokine-induced invasion and sequestered 
p120ctn away from p190RhoGAP, leading to RhoA 
inactivation (176).  
 In lung SCCs and adenocarcinomas, abnormal 
expression of p120ctn, including downregulation of both 
long and short isoforms, is associated with tumor 
progression and poor prognosis (177). Abnormal p120ctn 
expression, including complete loss, downregulation or 
mislocalization of p120ctn, correlated with abnormal E-
cadherin expression (including reduced or absent 
membrane expression of E-cadherin besides increased 
cytoplasmic expression of E-cadherin) and overexpression 
of RhoGTPases. Abnormal expression of p120ctn and E-
cadherin and overexpression of RhoGTPases were 
associated with malignant human lung cancer in vitro and 
in vivo (178). E-cadherin and p120ctn isoform 3 are 
expressed in normal bronchial epithelium, but p120ctn 
isoform 1 is upregulated and localized in the cytoplasm of 
squamous cell lung cancers and lung adenocarcinomas 
(179). Further analysis revealed that overexpression of 
p120ctn isoform 1 mRNA correlates significantly with 
abnormal E-cadherin expression, lymph node metastasis 
and poor differentiation (179). Another study confirmed a 
significant reduction of both long and short p120ctn 
isoforms in lung carcinomas compared to normal lung 
tissues (180). Somewhat surprisingly, expression of 
p120ctn isoform 3 mRNA and protein was found to 
positively correlate with lymph node metastasis (180). 
More recently, these investigators reported that expression 
of p120ctn isoform 3 in lung cancer cells inhibited in vivo 
tumor growth in nude mice but failed to block invasion 
(181). On the other hand, p120ctn isoform 1 effectively 
blocked invasion but not tumor growth. All together, 
p120ctn isoforms 1 and 3 appear to have opposing effects 
on invasion and proliferation in lung cancer cells due to 
differential regulation of RhoGTPase activity (see also 
Section 9.3.) and differential stabilization of cadherin-based 
junctions (181, 182). 
 
Little is known about the effects of the 
alternatively spliced internal exons of p120ctn on 
tumorigenesis. Exon B encodes a NES and is expressed in 
some human tissues, such as kidney, pancreas, colon, small 
intestine and prostate. Interestingly, expression of exon B is 
lost in the corresponding tumorigenic tissues (111), 
suggesting that during tumor progression p120ctn is shifted 
towards the nucleus, which relieves the repression of 
oncogenic target genes of Kaiso. 
 
9.3. Differential regulation of RhoGTPases by p120ctn 
in cancer  
In contrast to the dogma stating that p120ctn 
isoform 1 inhibits RhoA activity and activates Rac1 and 
Cdc42 (see Section 6), in lung cancer cells p120ctn isoform 
1 blocks Rac1 activity whereas p120ctn isoform 3 activates 
RhoA and inhibits Cdc42 activity (181). Knockdown of 
p120ctn in lung cancer cell lines results in inhibition of 
RhoA and activation of Rac1 and Cdc42 (182). Activated 
RhoA has also been observed in a mouse model of invasive 
lobular carcinoma (Patrick Derksen, Utrecht, personal 
communication). Treatment of these mice with the clinically 
approved Rock inhibitor Fasudil inhibited tumor growth in 
vivo. Activation of the RhoA/Rock pathway in cells derived 
from primary mouse invasive lobular carcinomas results in 
phosphorylation of cofilin. Phosphorylated cofilin was also 
found in human invasive lobular carcinoma samples (Patrick 
Derksen, personal communication). The explanation for the 
discrepancy between the dogma and RhoGTPase regulation in 
lung and breast cancer might be related to the presence or 
absence of E-cadherin. Indeed, the effect of p120ctn on Rac1 
activity depends on E-cadherin expression: knockdown of 
p120ctn results in Rac1 inhibition in E-cadherin-negative cells, 
but in Rac1 activation in E-cadherin-positive cells (183). The 
lung cancer cells used in the study of Liu et al. (181) were 
still expressing E-cadherin, and this might explain the 
inhibition of Rac1 induced by p120ctn isoform 1. However, 
since the mouse model for invasive lobular carcinoma 
involves genetic inactivation of E-cadherin, the deviant 
RhoA activity in these tumors cannot be explained by E-
cadherin expression but must have been caused by an 
unidentified mechanism. 
 
9.4. p120ctn isoforms: effects on proliferation and 
tumor growth 
p120ctn can regulate cell proliferation in different 
ways. Several lines of evidence show that p120ctn, and in 
particular high levels of cytoplasmic p120ctn, promotes cell 
proliferation and tumor growth. Such high cytoplasmic 
expression promotes transformed growth of both E-
cadherin-negative and -positive cells, and knockdown of 
p120ctn reduces the growth rate, as evidenced by a 
reduction in the proportion of cells in the S-phase (69, 183). 
Ras/MAPK signaling is important for the p120ctn-mediated 
growth effect, because RNAi-mediated depletion of 
p120ctn inactivates MAPK signaling in E-cadherin-
negative cells (183). Both p120ctn isoforms 1 and 4 as well 
as constitutively active Rac can reactivate MAPK signaling 
(183). On the other hand, AIG mediated by p120ctn 
isoform 1 could be blocked by a MEK inhibitor (183). In 
addition, primary keratinocytes deficient in p120ctn grow 
more slowly than their wild-type counterparts due to 
defects in mitosis and cytokinesis, including the generation 
of binucleate cells (165). A similar phenotype was 
observed upon knockdown of p0071 (50). The defects seen 
in cells devoid of either p0071 or p120ctn could be rescued 
by constitutively active RhoA and dominant negative 
RhoA, respectively (50, 165). 
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On the other hand, p120ctn can also block 
proliferation. p120 knockdown in NIH3T3 cells promotes 
serum-free cell proliferation and partial cell transformation 
(112). In E-cadherin-positive breast cancer cells, p120ctn 
depletion results in increased proliferation and activation of 
Ras-MAPK signaling (183). Expression of p120ctn isoform 
3 in E-cadherin-positive cells blocks cell proliferation, 
DNA synthesis and in vivo tumor growth (181, 184). Cells 
expressing p120ctn isoform 3 are arrested in the G1-S 
phase, and the transition from G1 to S phase depends on the 
cyclin-dependent kinase 2/Cyclin E complex. p120ctn 
isoform 3 associates with this complex and prevents its 
proteasomal degradation. This leads to S-phase 
lengthening, centrosome overduplication, and genomic 
instability (184). In contrast to p120ctn-deficient 
keratinocytes in culture (see above), genetic ablation of 
p120ctn in skin results in hyperproliferation and increased 
MAPK signaling (46). Cell proliferation is also increased in 
p120ctn-deficient colon and small intestine (47). These 
observations indicate that p120ctn might have different 
effects on cell growth in vitro and in vivo, and that the 
effects also depend on the cell type and the 
microenvironment. 
 
9.5. p120ctn isoforms: effects on motility and invasion 
RhoGTPases are key mediators of the dynamic 
rearrangements of the actin cytoskeleton (185), which are 
crucial for cell motility. The activity of several 
RhoGTPases is modulated by p120ctn (10-12). p120ctn-
mediated inhibition of RhoA activity decreases the number 
of stress fibers and focal adhesions, whereas p120ctn-
mediated activation of Rac1 and Cdc42 increases formation 
of, respectively, lamellipodia and filopodia. Overall, 
p120ctn expression is expected to alter cytoskeletal 
dynamics to favor cell motility and to enhance migration 
(11, 12). Several p120ctn knockdown studies have indeed 
revealed that p120ctn is important for cell migration and 
invasion. Cells devoid of p120ctn fail to repopulate the 
wounded area in a scratch assay (112). On the other hand, 
stable knockdown of p120ctn in E-cadherin-deficient cells 
resulted in decreased migration and invasiveness. These 
deficiencies could be rescued by reexpression of p120ctn 
isoform 1, but not by reexpression of cadherin-uncoupled 
p120ctn isoform 1 (71). Moreover, p120ctn induces 
invasiveness by its association with mesenchymal 
cadherins, such as N-cadherin or cadherin 11, whereas 
knockdown of these mesenchymal cadherins and the use of 
p120ctn-uncoupled mutants blocks invasiveness (71). 
Migration and invasion of E-cadherin-deficient cells is 
blocked by ectopic expression of E-cadherin (71). E-
cadherin might sequester p120ctn away from the 
mesenchymal cadherins, resulting in their endocytosis and 
degradation. Invasiveness can also be blocked by 
constitutively active RhoA and dominant negative 
Rac1expression, but is enhanced by inhibition of ROCK, a 
downstream effector of RhoA (71). The p120ctn-depleted 
cells have been employed for testing the potential of 
different p120ctn isoforms to induce invasion. Invasiveness 
is strongest upon expression of p120ctn isoform 1A, it is 
unaffected by p120ctn isoform 3A, and is blocked by 
p120ctn isoform 4 (186). In clear renal cell carcinomas, E-
cadherin is downregulated and p120ctn is translocated to 
the cytoplasm. Furthermore, p120ctn undergoes an isoform 
switch from predominantly short to long p120ctn isoforms. 
This switch is correlated with micrometastasis, which 
indicates that, at least for this cancer type, p120ctn isoform 
1 simulates invasiveness in vivo (186). p120ctn can also 
block invasion because p120ctn depletion in lung cancer 
cell lines enhances invasion and metastasis due to 
differential regulation of RhoGTPase activity (see Section 
9.3.) (182). To conclude, p120ctn isoforms affect migration 
and invasion in different ways by inducing RhoGTPase-
mediated rearrangements of the actin cytoskeleton. 
 
9.6. p120ctn and anchorage-independent growth 
Anchorage-independent growth (AIG) is a 
hallmark of tumor formation and is dependent on 
endogenous p120ctn. Stable knockdown of p120ctn in E-
cadherin-negative MDA-MB-231 cells abolished their 
ability to grow anchorage-independently in vitro (colony 
formation in soft agar) and in vivo (xenografts), but this 
effect could be rescued by re-expression of p120ctn 
isoform 1 (183). Endogenous p120ctn is also required for 
anchorage-independent survival of E-cadherin-negative 
mouse breast cancer cell lines; its depletion makes them 
more susceptible to anoikis. (Patrick Derksen, personal 
communication). Oncogenes, such as activated variants of 
Src and Rac1, can circumvent anoikis by activation of 
downstream survival and proliferation signals. In an E-
cadherin-negative setting, p120ctn attains oncogenic 
characteristics and might bypass anchorage dependence by 
activating the MAPK pathway (183). In addition, p120ctn 
promotes tumor growth via Rac1 activation, and expression 
of a constitutively active Rac1 mutant reverses the cell 
cycle defect and can rescue AIG in vitro and xenograft 
growth in vivo (183). E-cadherin, but not p120ctn-
uncoupled cadherin, can block both AIG and activation of 
Rac1 and Ras in the presence of p120ctn (183). Stable 
knockdown of p120ctn in E-cadherin-positive MCF7 cells 
results in reciprocal effects on AIG, Rac1 activity and 
MAPK signaling (183). However, the molecular 
mechanism is not clear because p120ctn knockdown also 
affects the E-cadherin expression levels. Depletion of 
endogenous E-cadherin in MCF7 cells phenocopies the 
effect of p120ctn knockdown, indicating that under normal 
conditions E-cadherin blocks AIG by inhibiting both Rac 
and Ras-mediated signaling (183). 
 
p120ctn ablation blocked AIG in cells 
transformed with Rac1 or Src, but not in cells transformed 
with H-Ras (69). AIG in cells transformed with Rac1 or Src 
is dependent on p120ctn-mediated RhoA inhibition because 
ablation of p120ctn in these transformed cells is rescued by 
inhibition of ROCK, a downstream RhoA effector (69). 
Activating the RhoA pathway by adding LIMK1, which is 
downstream of ROCK, also blocks AIG in transformed 
cells (69). RhoA activation results in phosphorylation and 
inactivation of cofilin at serine residue 3 (S3), whereas 
p120ctn-mediated RhoA inhibition results in cofilin 
activation. Strangely, in contrast to ROCK inhibition, AIG 
is not rescued by a dominant active S3A cofilin mutant that 
cannot be phosphorylated. So, other RhoA effectors might 
be involved in the regulation of AIG (69). The dependence 
of AIG on either Rac1 activation or RhoA inhibition might 
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be explained by the ‘Bar-Sagi’ pathway, in which Rac1 
activation results in RhoA inhibition (112). In conclusion, 
p120ctn is involved in AIG. The exact mechanism remains 
unclear but it might depend on the type of cellular 
transformation. 
 
9.7. p120ctn and the inflammation–cancer interaction 
A strong connection exists between inflammation 
and tumor progression (187). p120ctn depletion in mouse 
skin caused hyperproliferation and chronic inflammation 
due to increased NF-κB activation (46). Both general 
immunosuppressive drugs (Dexamethasone) and a NF-κB 
inhibitior (IKK2 inhibitor) reduced the hyperproliferation 
in p120ctn-deficient skin grafts (46, 165). The NF-κB 
activation in p120ctn-depleted keratinocytes is dependent 
on RhoA activity. Constitutively active RhoA and ROCK 
mutants result in nuclear translocation of NF-κB in wild-
type keratinocytes, whereas nuclear NF-κB expression can 
be reverted in p120ctn-deficient keratinocytes by 
expression of dominant-negative RhoA or by treatment 
with ROCK inhibitor (46). Moreover, nuclear NF-κB can 
also be reverted by introducing a cadherin-uncoupled 
p120ctn mutant, but not by a RhoA-uncoupled mutant 
(delta622-628) (46). So, NF-κB activation depends on 
RhoA activity, which in turn might be influenced by 
expression of the alternatively spliced exon C. Poorly 
differentiated human SCCs also showed nuclear NF-κB as 
well as perturbed expression and/or localization of p120ctn 
(165). Finally, genetic ablation of intestinal p120ctn also 
results in increased infiltration of COX-2-positive 
neutrophils, which is commonly seen in inflammatory 
bowel disease (47). This disease predisposes intestinal 
tissue to cancer (188).  
 
10. CONCLUSIONS AND PERSPECTIVES 
 
For a long time, p120ctn has stood in the shadow 
of its famous relative, beta-catenin, which has exceptional 
features as both junctional component and tumorigenic 
transcriptional activator. However, it has now become clear 
that p120ctn has many characteristics that make it stand out 
from beta-catenin as a unique intracellular regulator, at 
least in vertebrates. 
 
What p120ctn shares with other members of the 
Armadillo protein family is, of course, the central 
Armadillo repeat domain, which nevertheless exhibits 
differences in structure and function among the family 
members. What makes p120ctn unique in relation to 
beta-catenin is its binding to an evolutionarily conserved 
juxtamembrane domain of cadherins, the occurrence of 
multiple isoforms generated by alternative splicing, its 
tight regulation by multiple phosphorylation events, and 
its binding to various unique interaction partners, 
including kinases and linkers to the microtubular 
cytoskeleton. This translates into several site-specific 
intracellular functions: cadherin stabilization at 
intercellular junctions, Rho family member modulation 
in the cytoplasm, control over the transcriptional 
repressor Kaiso, and modulation of the canonical Wnt 
signaling pathway. These findings imply that the 
ubiquitously expressed p120ctn may turn out to be a key 
regulator of intracellular signaling and tissue 
organization. Indeed, in the embryos of frog and mouse, 
p120ctn is indispensable for early development, and 
studies of conditional knock-out mice point to important 
roles in morphogenesis and homeostasis.  
 
p120ctn represents the prototype of a small 
Armadillo protein subfamily that includes ARVCF, delta-
catenin and p0071. Much less is known about the specific 
functions of the other members, but a few mouse models 
indicate that they cannot compensate for the loss of 
p120ctn, whereas p120ctn can at least in part compensate 
for loss of the others. Nonetheless, the other subfamily 
members deserve further analysis because of their possible 
involvement in some human diseases. The next steps in 
their study could include generation of mice with more 
complex genotypes, combining knock-outs of one 
Armadillo subfamily member with knockout of the most 
related family member, or triggering knock-outs by various 
predisposing conditions. 
 
Regarding p120ctn itself, numerous associations 
have been reported between p120ctn dysregulation on the 
one hand and tumorigenesis and tumor progression on the 
other hand. However, as might be expected from the 
pleiotropic roles of p120ctn under physiological conditions, 
these interactions are complex. Often seen is either the loss 
of p120ctn or its cytoplasmic accumulation. Another 
recurrent observation is the switch to longer isoforms 
during epithelial-to-mesenchymal transition (EMT), which 
leads to increased tumor malignancy. How such changes in 
p120ctn expression modify intra- and intercellular signaling 
and cause complex pathological cellular behavior is under 
investigation.  
 
 Some suggestions to further scrutinize the 
regulatory roles of p120ctn family members can be made. 
Instead of deleting large parts of protein domains, one may 
zero in with point mutations affecting specific 
posttranslational modifications or the binding to any of the 
many interaction partners of p120ctn, including cadherins, 
RhoGTPases, kinases and phosphatases, cytoskeleton-
associated proteins, and transcriptional regulators. That all 
this can be achieved is exemplified by recent studies 
targeting phosphorylation sites in p120ctn (132, 133), the 
generation of p120ctn-uncoupled mutations in classic 
cadherins (66), and the generation of a short deletion 
affecting one particular RhoA binding site in p120ctn 
(10). Generation of constitutive or conditional knock-in 
mice for these very particular mutations may reveal 
more clearly the multiple and context-dependent in vivo 
roles of p120ctn. For instance, our laboratory generates 
mice in which particular isoforms of p120ctn are either 
excluded or constitutively expressed. As for the link of 
p120ctn to cancer, it is intriguing that so few somatic 
p120ctn mutations have been reported in human tumors. 
The molecular mechanisms by which p120ctn is 
inactivated or otherwise modulated in cancer needs to be 
addressed in detail. Also, more informative animal 
models need to be generated in order to elucidate the 
role of changes in p120ctn in various diseases, and 
particularly in cancer. 
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